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ABSTRACT 
Objectives of the review: The decision whether to include postoperative radiotherapy on 
patients with oral squamous cell carcinoma depends on the risk of local recurrence. The 
objectives of this study were to systematically review literature on whether perineural 
invasion in oral squamous cell carcinoma patients is associated with higher local recurrence 
rates and whether local recurrence is influenced by the administration of postoperative 
radiotherapy in patients presenting with perineural invasion. 
Type of review: Systematic review. 
Search strategy: Embase, PubMed, WebOfScience. 
Evaluation method: The databases above were searched for studies that analysed: the 
treatment of oral squamous cell carcinoma patients with perineural invasion; local recurrence; 
and postoperative radiotherapy. The data of seven studies were analysed qualitatively.  
Results: The overall quality of the studies was moderate to low. There was no evidence of 
the effect of postoperative radiotherapy on local recurrence rates in patients presenting with 
perineural invasion. Some evidence suggests that local recurrence rates may increase in cases 
of multifocal perineural invasion, especially if nerves >1 mm are involved but these data 
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Conclusions: High quality evidence regarding the prognostic value of perineural invasion 
and the impact of postoperative radiotherapy in patients presenting with perineural invasion is 
lacking in the literature, making it difficult to select a post-operative strategy for early stage 
tumours.   
 




Surgical resection is the primary treatment modality of oral squamous cell carcinoma 
(OSCC). The decision whether to apply postoperative radiotherapy (PORT) depends on the 
risk of local or loco-regional recurrence (LR)
1-4
. To improve local control in advanced 
disease (stage III-IV), surgical resection is followed by PORT. In early stage tumours (I-II) 
there is often no indication for radiotherapy. However, PORT should be given to cases with 
high risk of recurrence such as positive surgical margins (< 1mm), multiple affected lymph 
nodes (N2b) and extracapsular extension, in order to improve loco-regional control5. It is 
not entirely clear in intermediate risk cases of early stage OSCC with close margins (1-5mm), 
poor differentiation, pT3-4, lymphangio invasion and perineural invasion (PNI), as to when 
PORT should be applied
5
. There is a need for research regarding adjuvant radiotherapy in 
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The risk of LR in the presence of PNI is unclear
2,7-10
. Some studies found a significant 
increase in LR rates in PNI cases
10-12
, while other studies did not
13,14
. Moreover, it is not clear 
whether PORT has an additional, positive effect in reducing the local recurrence rate in early 
OSCC with PNI. Evidence regarding prognosis is needed to justify the role of PORT, because 




The objectives of this study were to systematically review the literature to find 
whether PNI in OSCC patients is associated with a higher LR rate and whether LR rate is 
influenced by administration of PORT in OSCC patients presenting with PNI. 
 
METHODS 
Study identification and selection 
The study protocol was designed using the PRISMA statement for reporting systematic 
reviews and meta-analyses.
18
 A search protocol was developed prior to the study. Studies 
were sought in electronic databases namely, PubMed, Embase and Web of Science. The last 
search date was September 18
th
 2017. No limitations were applied regarding time of study or 
study design. Only studies written in English were included. A general search strategy was 
developed together with an information specialist and adapted appropriately to each database 
(Appendix 1). Publications were included if they described: the treatment of patients with 
squamous cell carcinoma of the oral cavity; PNI; local recurrence; whether PORT was given 
or not; and a sample size of ≥ 10. Local recurrence was deﬁned as histopathologically proven 
tumour arising within 10mm from the primary tumour. Publications were excluded if 
brachytherapy was given, if pre-operative radiotherapy or other earlier treatments were 
provided, if recurrent or secondary tumours were included, if pathological T stage was not 
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 First, titles were assessed for selection by two observers independently (JV and KS). 
Abstracts from the included titles were then assessed by the same observers. Titles with 
insufficient information or causing disagreement between the observers were also included 
for abstract assessment.  If an abstract provided insufficient information or disagreement 
existed between observers, the text was checked. Thereafter, full text papers were assessed in 
a similar way. Finally, the references of the included studies were also perused for inclusion 
and if any were selected, the same procedure was followed as described above. Studies in 
which only a part of the study group met the inclusion criteria, were included for further 
analysis of the relevant group.  Inter-observer agreement was expressed as Cohen’s κ and as a 
percentage of agreement.   
In cases of disagreement about inclusion or exclusion, a decision was made by 
consensus. A third reviewer (MJHW) was consulted to resolve remaining disagreements.  
 
Data extraction 
The relevant data of the included papers were extracted onto a standardized form by the first 
author (JV) according to the following categories: dates over which the study was conducted; 
patient characteristics; tumour characteristics (including location in the oral cavity, T-stage 
and histopathologic factors); adjuvant (chemo)radiotherapy (including chemotherapy agent 
and dosing, technique of radiotherapy and dose and fractionation of the radiation); and local 
recurrence (in relation to PNI and adjuvant radiotherapy). All data extraction was verified by 
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Study quality assessment 
The quality of the included studies was assessed based on the ‘Newcastle-Ottawa Scale 
(NOS) for assessing the Quality of Nonrandomized Studies
19
 by the first author. These 
included the study groups, comparability of the groups and ascertainment of outcome of 




The searches in Pubmed, Embase and Web of Science yielded 976, 1755 and 63 hits 
respectively (Fig.1). After deduplicatation, 2085 papers remained. The interobserver 
agreement for title and abstract selection was 0.73 (SE 0.029) and absolute agreement was 
95.7%. Following title and abstract selection, 119 papers remained for full text assessment 
(interobserver agreement 0.61 (SE 0.089), absolute agreement 97.5%) after which a total of 
13 studies were potentially eligible for inclusion in this systematic review. A reference check 
did not result in additional relevant studies. Six of the 13 studies were excluded because of 
insufficient data or irrelevant comparisons. Qualitative data analysis was performed on the 
remaining seven studies. Data synthesis was not performed because of the heterogeneity of 
the study designs and populations. 
 
Characteristics of included studies 
All studies were retrospective cohorts published between 2011 and 2016. Sample size ranged 
from 78 to 442 patients (Table 1). All the studies included primary tumours of the oral cavity 
with surgery as a primary treatment. The definition of PNI differed between the studies. The 
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nerve sheath and/or tumour cells in close proximity to the nerve involving more than one 
third of its circumference
1,8,20
. In another study, the definition of PNI was  limited to the 
presence of tumour cells within any of the three layers of the nerve sheath
21
 and another three 
studies did not define PNI at all
22,23
. Three studies included patients with all pathological T-
stages
1,21,24
, whereas four studies included patients solely with pT1-2 tumors
22,23,25
. Two 
studies excluded patients with positive or close resection margins
1,23
.   All the studies 
reported the resection margins, but only five studies defined them
1,20,23-25
. Other 
histopathologic features were described adequately in five studies
8,20-22,25
. One study 
excluded patients with adverse histopathologic factors such as extracapsular spread and 
lymphangio invasion
1
. In five studies, patients were treated with PORT, but no specific 
indication regarding PNI was reported
1,8,20,21,23
. Of those studies, four reported that 
PORT
1,8,20,23
 was applied to 3.6-43.4% of the patients. One study did not report which 
patients were treated with PORT
21
. Two other studies excluded the patients treated with 
PORT
22,25
. All the studies analysed different variables, but all had local recurrence as either a 
primary or secondary outcome.   
 
Local recurrence 
None of the seven studies reported PNI as a significant prognostic factor for LR; however, 
one study reported PNI as a significant prognostic factor if it was presenting multifocally, 
especially if nerves >1mm were involved (p=0.049)
8
. None of the seven included studies 
evaluated the impact of PORT in patients presenting with PNI. A summary of study findings 
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DISCUSSION 
Summary of main results 
We used a systematic review to investigate the impact of PNI on LR in OSCC patients and 
whether LR is influenced by the administration of PORT. Only seven studies could be 
included and these papers only partly answered the research questions; therefore, high quality 
evidence regarding the impact of PNI on LR rates in patients with OSCC is lacking. All 
studies reported that there was no significant difference in LR between patients presenting 
with and without PNI. However, one study reported that PNI was a significant prognostic 
factor when it is multifocal, especially if nerves >1 mm are involved. None of the included 
studies reported the impact of PORT on LR in patients presenting with PNI.  
 
Comparison with other reviews 
An earlier systematic review reported that PNI is not a significant prognostic factor for 
locoregional recurrence
26
. That systematic review included studies describing squamous cell 
carcinoma in the complete head and neck area and studies only reporting clinical T stage 
were not excluded. Also, local and regional recurrences were listed as locoregional 
recurrence irrespective of whether these types of recurrences had other aetiologies. Our aim 
was to evaluate the impact of PNI on LR more precisely by excluding studies only reporting 
clinical T stage and those only including OSCC. A partially retrospective and partially 
prospective study reported PNI as an independent predictor of LR if nerves >1mm were 
involved
10
, however this study was excluded in our study because pathological T stage was 
not described and squamous cell carcinoma of the pharynx was also included. Another study 
did not find any association between nerve size and LR, however this might be explained by 
the fact that only nerves smaller than 1mm were encountered in that study
9
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PNI was evaluated by Chinn et al. on attempting to demonstrate an association between the 
extent of PNI and the size of the nerves involved, but they failed, probably due to the lack of 




Overall completeness and applicability of evidence 
The major limitation of the current literature is the lack of a standardized definition of PNI. 
Based on the results of the present systematic review, there is a need for a standardized 
definition of PNI in order to obtain exact numbers of its incidence and to evaluate the 
association between PNI and prognosis.  
Furthermore, the majority of the included studies did not describe the location, size of 
the involved nerves and the extent of PNI. Aivazian et al. reported a clinically significant 
difference between the prognostic value of unifocal and multifocal PNI, especially combined 
with invasion of nerves greater than 1mm
8
; therefore, it seems it is not enough to only report 
PNI as absent or present.  
 Finally, there was no data available on the selection criteria of patients receiving 
adjuvant treatment because of PNI. Therefore, it remains unclear at which point PORT was 
administered to the PNI positive and the PNI negative group and no conclusions can be 
drawn about the additional effect of PORT on LR. 
Quality of evidence 
Although over 2000 papers were identified in the database search, only seven papers could be 
included in this systematic review. A very common reason for exclusion was the non- 
reporting of pathological T-stage; only clinical T-stage was reported. Pathological T-stage is 
essential to evaluate prognosis. Furthermore, pT1-2 tumours are clinically most important 
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early-stage tumours, whereas most institutes use pT3-4 tumours as an indication for PORT
5
. 
Also a considerable number of studies were excluded because locoregional recurrence was 
reported instead of separate local and regional recurrence. The level of evidence of the 
included studies was limited because of their retrospective design. 
 
Implications for research 
In order to determine the indication for PORT, prospective studies need to be done to 
investigate the effect of PORT in patients presenting with PNI on LR. It would be important 
to introduce a standardized definition of PNI to obtain exact incidence rates. Also, the extent 
of PNI should be described more specifically by means of the location and the size of the 
involved nerves. Finally, accurate data registration including precise description of the 
cohort, pathological T- and N-stages, resection margins, local recurrence and other 
pathological tumour characteristics (such as depth of invasion, pattern of growth and 
lymphovascular invasion) would be essential in order to evaluate prognosis.  
 
Conclusion 
Based on the available evidence, it is not clear whether there is an indication for PORT in 
unifocal PNI; moreover, high quality evidence is lacking on the impact of PORT in OSCC 
patients presenting with PNI. 
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TABLES AND FIGURES 
Figure 1: Flow chart of the selection process. 
 
Table 1: Study characteristics 
Abbreviations: n, number; RC, retrospective cohort; RT, radiotherapy; CRT, chemoradiotherapy; 
NOS, Newcastle-Ottawa Scale; NR, not reported. 
* 
Median. 
§ Mean.  
† Memorial Sloan-Kettering Cancer Center (New York, NY) and Princess Margaret Cancer Center 
(Toronto, Ontario, Canada). 
 
Table 2: Summary of study findings.  
Abbreviations: n, number; PNI+, perineural invasion-positive; PNI-, perineural invasion-negative; LR, local 
recurrence; HR, hazard ratio; NS, not significant. 
* 
These numbers represent T1 and T2 or T3 and T4 cases. 
§ There were also a number of patients in which PNI was not reported. 
† PNI and lymphovascular invasion were combined as a high risk group in the calculations of local recurrence. 
†† Local recurrence rates were calculated in patients who did not receive post-operative radiotherapy. 
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Table 1: Study characteristics 
Author, publication year  Tai, 2011 
24
 Ganly, 2012 
19
 Chen, 2013 
20












Country Taiwan USA Taiwan USA Australia Japan  Australia 













Sydney Head and 
Neck Cancer 
Institute 
Design RC RC RC RC RC RC RC 
Study period 2001-2009 1985-2005 2004-2009 2005-2011 1995-2010 2001-2011 1988-2013 
Data source Medical records NR Medical records 
& Pathologic 
reports 
NR Medical records Medical records NR 
Total sample (n) 307 164 442 78 318 89 121 
Male ( n) 267 90 374 55 194 50 75 








64* (30-92) >63, n=48 
≤63, n=41 
61*(47-74) 
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Surgery 
Surgery + RT 


























(62.8 Gy PNI+ 
60 Gy PNI-) 
- NR NR  
(50-70 Gy) 
NR NR - 
Type of chemotherapy Cisplatin  - - - NR - - 














This article is protected by copyright. All rights reserved. 











































in PNI+ patients 
Local recurrence 














































































89 82* 7* - - 23% - - 26% - NS 





























Studies identified through database 
searching after duplicates removed 
(n =  2085) 
Additional studies identified through 
other sources 
(n = 0) 
Studies screened on title and 
abstract 
(n = 2085) 
Studies excluded 
(n = 1938) 
Full-text articles assessed for 
eligibility 
(n = 147) 
Full-text articles excluded, with reasons 
(n = 140) 
 No full text available    n = 43 
 Other location than oral cavity  n = 35 
 Clinical T-stage   n = 21 
 Locoregional recurrence  n = 22 
 Recurrent tumor   n = 3 
 No reporting of PNI   n = 6 
 Wrong study design   n = 2 
 No English language    n = 1 
 Study not finished yet   n = 1 
 
 Wrong comparison   n = 4 
 Insufficient data   n = 2 
 
 
Studies eligible for inclusion  
(n = 13) 
Studies included in 
qualitative synthesis  
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APPENDIX 1: Search strategy 
Pubmed 
("Mouth"[Mesh] OR "Mouth Neoplasms"[Mesh] OR tongue[tiab] OR oral[tiab] OR 
mouth[tiab] OR gingiva*[tiab]) 
AND ("Mouth Neoplasms"[Mesh] OR OSCC[tiab] OR SCC[tiab] OR squamous cell[tiab] OR 
cancer[tiab] OR carcinoma*[tiab] OR tumour*[tiab] OR tumor*[tiab])  
AND ("Radiotherapy, Adjuvant"[Mesh] OR "Chemoradiotherapy"[Mesh] OR "radiotherapy" 
[Subheading] OR chemoradiother*[tiab] OR chemo radio therap*[tiab] OR radio chemo 
therap*[tiab] OR radiochemother*[tiab] OR (chemoradio*[tiab] AND  therap*[tiab]) OR 
(radiochemo*[tiab] AND therap*[tiab]) OR radiother*[tiab] OR (radiation[tiab] AND 
(postoperative[tiab] OR post-operative[tiab] OR adjuvant[tiab])))  
AND ("Neoplasm Recurrence, Local"[Mesh] OR "Mortality"[Mesh] OR "Survival"[Mesh] 
OR recurren*[tiab] OR surviv*[tiab] OR mortality[tiab] OR death*[tiab])  
AND  ("Neoplasm Invasiveness"[Mesh] OR Perineural[tiab] OR invasi*[tiab] OR 
characteristic*[tiab] OR agressi*[tiab]) 
Embase 
('Mouth'/exp OR 'mouth cancer'/exp OR 'tongue tumor'/exp OR tongue:ab,ti OR oral:ab,ti OR 
mouth:ab,ti OR gingiva*:ab,ti )  
AND  
('mouth cancer'/exp OR 'tongue tumor'/exp OR oscc:ab,ti OR scc:ab,ti OR 'squamous cell’:ab,ti 
OR cancer:ab,ti OR carcinoma*:ab,ti OR tumour*:ab,ti OR tumor*:ab,ti)  
AND  
('cancer adjuvant therapy'/exp OR 'cancer radiotherapy'/exp OR chemoradiother*:ab,ti OR 
((chemoradio* OR radiochemo*) NEXT/1 therap*):ab,ti OR radiochemother*:ab,ti OR 
radiother*:ab,ti OR (chemo* NEAR/3 radio* NEAR/3 therap*):ab,ti OR (radiation AND 
(postoperative OR 'post operative’ OR adjuvant)):ab,ti)   
AND   
('cancer mortality'/exp OR 'cancer recurrence'/exp OR 'cancer survival'/exp OR recurren*:ab,ti 
OR surviv*:ab,ti OR mortality:ab,ti OR death*:ab,ti)   
AND  
('tumor invasion'/exp OR perineural:ab,ti OR invasi*:ab,ti OR characteristic*:ab,ti OR 
agressi*:ab,ti)   
Web Of Science  
TS=("mouth” OR “tongue” OR gingiva* OR “oral”)   
AND   
TS=(cancer* OR tumour* OR tumor* OR carcinoma* OR neoplasm* OR “scc” OR “oscc” 
OR “squamous cell”)  
AND   
(TS=(chemo* NEAR/3 radio* NEAR/3 therap*) OR TS=(chemoradio* OR radiochemo* OR 
radiotherap*) OR TS=(“radiation” AND (“postoperative” OR “post operative” OR 
“adjuvant”)))   
AND   
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AND   
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